Ellevest, Inc. Igm Biosciences, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$13.74 - $25.76 $247 - $463	-18 Reduced 62.07%	11 $0
Q4 2022 Feb 03, 2023	SELL	$15.45 - $26.02 $648 - $1,092	-42 Reduced 59.15%	29 $0
Q3 2022 Nov 02, 2022	SELL	$15.42 - $27.01 $308 - $540	-20 Reduced 21.98%	71 $2,000
Q2 2022 Jul 18, 2022	BUY	$13.27 - $25.5 $1,101 - $2,116	83 Added 1037.5%	91 $2,000
Q1 2022 Apr 19, 2022	BUY	$13.42 - $29.73 $107 - $237	8 New	8 $0

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.